Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0FY1W
|
||||
Former ID |
DIB001969
|
||||
Drug Name |
Thymidine kinase-expressing adenovirus and ganciclovir suicide gene therapy
|
||||
Synonyms |
Thymidine kinase-expressing adenovirus and ganciclovir suicide genetherapy (cancer); Ad5-SSTR/TK-RGD; Thymidine kinase-expressing adenovirus and ganciclovir suicide gene therapy (cancer), University of Alabama
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Phase 1 | [522769] | ||
Company |
University of Alabama at Birmingham
|
||||
Target and Pathway | |||||
Target(s) | Thymidine kinase | Target Info | Modulator | [1572591] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.